Second Photo
fundable.
DATA PLATFORM
  • Dashboard
  • Companies
  • People
  • Investment Firms
  • Angels & Partners
COLLECTIONS
  • Lists
  • Saved Searches
  • Hiring Lists
WORKFLOWS
  • Deal Alerts
  • Integrations
  • API + Credits


logo
Crescendo Biologics logo

Crescendo Biologics

Recent Finacing

Equity

Recent Raise

$32M

Crescendo Biologics is a Cambridge-based clinical-stage immuno-oncology company developing Humabody VH domain–based multi‑functional therapeutics via a transgenic mouse VH discovery platform, including bispecific T‑cell engagers like CB307.

Founded 2007
Cambridgeshire, United Kingdom
51-100
Private
crescendobiologics.com

Highlights

Focus Areas

Biotechnology
Health Care
Therapeutics

Recent Investors

Sofinnova Partners logo
IP Group logo
Andera Partners logo
Quan Capital logo
EMBL Ventures logo
Imperial Innovations logo
Astellas Venture Management logo
Takeda Ventures logo
B
Takeda logo
Kreos Capital logo
Aitua logo

Financials

$139.9M

Total Raised

5

Funding rounds

14

Investors


Team

Upgrade to view the team

See the team members at Crescendo Biologics.